BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31858558)

  • 1. MiR-491 functions as a tumor suppressor through Wnt3a/β-catenin signaling in the development of glioma.
    Meng Y; Shang FR; Zhu YL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10899-10907. PubMed ID: 31858558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
    Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
    Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/
    Lv X; Li J; Hu Y; Wang S; Yang C; Li C; Zhong G
    Oxid Med Cell Longev; 2019; 2019():5703764. PubMed ID: 31178968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
    Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
    Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
    Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
    Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.
    Zhao C; Wang XB; Zhang YH; Zhou YM; Yin Q; Yao WC
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6369-6378. PubMed ID: 30338805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
    Chen Y; Deng X; Chen W; Shi P; Lian M; Wang H; Wang K; Qian D; Xiao D; Long H
    Cell Death Dis; 2019 Jun; 10(6):448. PubMed ID: 31171769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
    Zhang D; Guo S; Wang H; Hu Y
    Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells.
    Lu F; Ye Y; Zhang H; He X; Sun X; Yao C; Mao H; He X; Qian C; Wang B; Xie L; Xie T; Lu G; Zhang S
    Int J Biol Macromol; 2018 Dec; 120(Pt A):985-991. PubMed ID: 30171955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19.
    Zhang L; Cao Y; Jia D; Wei M
    Biochem Biophys Res Commun; 2019 Apr; 511(3):619-625. PubMed ID: 30826062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA 10a induces glioma tumorigenesis by targeting myotubularin-related protein 3 and regulating the Wnt/β-catenin signaling pathway.
    Yan Y; Yan H; Wang Q; Zhang L; Liu Y; Yu H
    FEBS J; 2019 Jul; 286(13):2577-2592. PubMed ID: 30927504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/β-Catenin Pathway.
    Wang Y; Yang Q; Cheng Y; Gao M; Kuang L; Wang C
    Med Sci Monit; 2018 Dec; 24():9110-9119. PubMed ID: 30552850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.